JP2022509240A - 抗ウイルス組成物 - Google Patents

抗ウイルス組成物 Download PDF

Info

Publication number
JP2022509240A
JP2022509240A JP2021530309A JP2021530309A JP2022509240A JP 2022509240 A JP2022509240 A JP 2022509240A JP 2021530309 A JP2021530309 A JP 2021530309A JP 2021530309 A JP2021530309 A JP 2021530309A JP 2022509240 A JP2022509240 A JP 2022509240A
Authority
JP
Japan
Prior art keywords
oil
lip balm
butter
wax
lip
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021530309A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022509240A5 (https=
Inventor
キャラダイン，ダニエル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Calladine Pharmaceuticals Ltd
Original Assignee
Calladine Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calladine Pharmaceuticals Ltd filed Critical Calladine Pharmaceuticals Ltd
Publication of JP2022509240A publication Critical patent/JP2022509240A/ja
Publication of JP2022509240A5 publication Critical patent/JP2022509240A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2021530309A 2018-11-29 2019-11-28 抗ウイルス組成物 Pending JP2022509240A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1819418.3 2018-11-29
GBGB1819418.3A GB201819418D0 (en) 2018-11-29 2018-11-29 Anti-viral compositions
PCT/EP2019/082850 WO2020109442A1 (en) 2018-11-29 2019-11-28 Anti-viral compositions

Publications (2)

Publication Number Publication Date
JP2022509240A true JP2022509240A (ja) 2022-01-20
JP2022509240A5 JP2022509240A5 (https=) 2022-12-02

Family

ID=65024906

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021530309A Pending JP2022509240A (ja) 2018-11-29 2019-11-28 抗ウイルス組成物

Country Status (8)

Country Link
US (1) US12295956B2 (https=)
EP (1) EP3886861B1 (https=)
JP (1) JP2022509240A (https=)
AU (1) AU2019389762B2 (https=)
CA (1) CA3121051A1 (https=)
ES (1) ES3035188T3 (https=)
GB (1) GB201819418D0 (https=)
WO (1) WO2020109442A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240350570A1 (en) * 2023-04-19 2024-10-24 Daniel Tyler WHITING Topical skin care preparation comprising ephedra viridis

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60132910A (ja) * 1983-11-09 1985-07-16 ロリアル 易酸化性活性物質の局所塗布用の薬用または化粧用棒またはステイツクおよびそのケ−ス
JP2001503404A (ja) * 1996-10-31 2001-03-13 レコルダチ エッセ．ア．ケミカル アンド ファーマシューティカル カンパニー 局所的塗布具のためのアシクロビルを含む抗ヘルペス薬学的組成物
JP2003128521A (ja) * 2001-10-16 2003-05-08 Rohto Pharmaceut Co Ltd 外用製剤
JP2009545607A (ja) * 2006-08-04 2009-12-24 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド ウイルス性疾患の治療のための抽出物の使用
JP2010506834A (ja) * 2006-10-11 2010-03-04 ワイス エルエルシー スティックリップバーム
US20100135945A1 (en) * 2008-12-02 2010-06-03 Kreations By Kristin, Llc Gymnema-containing lip balm compositions and associated methods
JP2010521490A (ja) * 2007-03-19 2010-06-24 イーエルシー マネージメント エルエルシー 高い光沢を有するスティック状化粧品
JP2010523511A (ja) * 2007-04-05 2010-07-15 エッカルト ゲゼルシャフト ミット ベシュレンクテル ハフツング 真珠光沢顔料含有化粧料組成物
US20130142881A1 (en) * 2011-12-02 2013-06-06 The Mothervine Nutraceutical Co. Llc Lip Balm Composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
DK169121B1 (da) 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
RU2093140C1 (ru) 1995-03-09 1997-10-20 Товарищество с ограниченной ответственностью "Снежный Барс" Лечебно-профилактическая помада и способ ее приготовления
AU2036297A (en) 1996-03-20 1997-10-10 Glaxo Group Limited Topical formulations of aciclovir
FR2773032B1 (fr) 1997-12-22 2001-12-21 Nortel Matra Cellular Modulation d'un signal numerique a spectre etroit et a enveloppe sensiblement constante
ITMI981528A1 (it) 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma Formulazioni topiche di aciclovir
RU2282473C2 (ru) * 2002-02-04 2006-08-27 Закрытое акционерное общество "Эвалар" Лечебно-профилактическая помада с противовирусной активностью и способ ее приготовления
US8697712B2 (en) 2004-04-05 2014-04-15 Laboratorios Liomont, S.A. De C.V. Presentation of an antiviral pharmaceutical composition
CN100562631C (zh) 2007-04-05 2009-11-25 崔文瀛 球网壳组合结构
WO2013077881A1 (en) 2011-11-23 2013-05-30 3B Pharmaceuticals, Inc. Antiviral formulations
BE1022817B1 (nl) * 2015-08-25 2016-09-13 Stasisport Pharma Nv Antivirale samenstelling en lippenstift omvattende genoemde samenstelling

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60132910A (ja) * 1983-11-09 1985-07-16 ロリアル 易酸化性活性物質の局所塗布用の薬用または化粧用棒またはステイツクおよびそのケ−ス
JP2001503404A (ja) * 1996-10-31 2001-03-13 レコルダチ エッセ．ア．ケミカル アンド ファーマシューティカル カンパニー 局所的塗布具のためのアシクロビルを含む抗ヘルペス薬学的組成物
JP2003128521A (ja) * 2001-10-16 2003-05-08 Rohto Pharmaceut Co Ltd 外用製剤
JP2009545607A (ja) * 2006-08-04 2009-12-24 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド ウイルス性疾患の治療のための抽出物の使用
JP2010506834A (ja) * 2006-10-11 2010-03-04 ワイス エルエルシー スティックリップバーム
JP2010521490A (ja) * 2007-03-19 2010-06-24 イーエルシー マネージメント エルエルシー 高い光沢を有するスティック状化粧品
JP2010523511A (ja) * 2007-04-05 2010-07-15 エッカルト ゲゼルシャフト ミット ベシュレンクテル ハフツング 真珠光沢顔料含有化粧料組成物
US20100135945A1 (en) * 2008-12-02 2010-06-03 Kreations By Kristin, Llc Gymnema-containing lip balm compositions and associated methods
US20130142881A1 (en) * 2011-12-02 2013-06-06 The Mothervine Nutraceutical Co. Llc Lip Balm Composition

Also Published As

Publication number Publication date
CA3121051A1 (en) 2020-06-04
EP3886861A1 (en) 2021-10-06
EP3886861B1 (en) 2025-05-07
US12295956B2 (en) 2025-05-13
ES3035188T3 (en) 2025-08-29
US20220016124A1 (en) 2022-01-20
AU2019389762B2 (en) 2025-07-31
GB201819418D0 (en) 2019-01-16
EP3886861C0 (en) 2025-05-07
WO2020109442A1 (en) 2020-06-04
AU2019389762A1 (en) 2021-07-01

Similar Documents

Publication Publication Date Title
US6911211B2 (en) Pharmaceutical and cosmetic carrier or composition for topical application
Sahu et al. Skin cream as topical drug delivery system: a review
CA2768423A1 (en) Soothing agents
US12582615B2 (en) Topical analgesic gel compositions
US12097186B2 (en) Topical analgesic compositions
US20220110993A1 (en) Compositions for treatment of jaw pain, temporomandibular joint and muscle disorder and bruxism
JP2005162728A (ja) 局所用途のためのムピロシン組成物、これを作成する改良プロセス、およびこれを用いる方法
US12295956B2 (en) Anti-viral compositions
US8383166B2 (en) Stable hydrophobic topical herbal formulationn
CA2518329C (en) Rapidly absorbing lipophilic skin compositions and uses therefor
JP7301824B2 (ja) マスク塗布用製剤
WO2021090058A2 (en) Metered dose for demodex and disorders related thereto
JP2001500145A (ja) 局所的使用のための製剤
JPH0353286B2 (https=)
JPH0539225A (ja) 外用剤
JP2022509240A5 (https=)
JP6484251B2 (ja) ミツバチ生成物を含む組成物
JP2023183349A (ja) 固形外用組成物
JP2003055185A5 (https=)
WO2024158585A1 (en) Dual-purpose analgesic cosmetic composition
US20240245630A1 (en) Dual-purpose analgesic cosmetic composition
WO2025006377A1 (en) Topical composition for pain relief
JP2003096304A (ja) 油性液状組成物
Sahu et al. Journal of Pharmaceutical and Biological Sciences
MXPA99003904A (en) Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221124

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221124

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231106

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240402

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240625

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240925

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20241223